Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13304-13312
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304
Table 4 Relationship between serum Spondin-2 expression and prognosis in patients with cervical cancer (mean ± SD)
| Group | n | PFS (mo) | OS (mo) |
| High Spondin-2 group | 101 | 23.2 ± 9.3 | 26.8 ± 8.7 |
| Low Spondin-2 group | 46 | 28.9 ± 10.4 | 30.1 ± 9.7 |
| t value | - | 3.319 | 2.056 |
| P value | - | 0.001 | 0.042 |
- Citation: Zhang LL, Lin S, Zhang Y, Yao DM, Du X. Serum Spondin-2 expression, tumor invasion, and antitumor immune response in patients with cervical cancer. World J Clin Cases 2022; 10(36): 13304-13312
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13304.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13304